These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35951200)

  • 1. Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications.
    Bai Y; Wu J; Yang Z; Wang X; Zhang D; Ma J
    Cell Biol Toxicol; 2023 Feb; 39(1):33-51. PubMed ID: 35951200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial scenario: roles of mitochondrial dynamics in acute myocardial ischemia/reperfusion injury.
    Mui D; Zhang Y
    J Recept Signal Transduct Res; 2021 Feb; 41(1):1-5. PubMed ID: 32583708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury.
    Yang M; Linn BS; Zhang Y; Ren J
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2293-2302. PubMed ID: 31100337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.
    Venkatesh S; Li M; Saito T; Tong M; Rashed E; Mareedu S; Zhai P; Bárcena C; López-Otín C; Yehia G; Sadoshima J; Suzuki CK
    J Mol Cell Cardiol; 2019 Mar; 128():38-50. PubMed ID: 30625302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury.
    Huang J; Li R; Wang C
    Oxid Med Cell Longev; 2021; 2021():5543452. PubMed ID: 34211627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.
    Hall AR; Burke N; Dongworth RK; Kalkhoran SB; Dyson A; Vicencio JM; Dorn GW; Yellon DM; Hausenloy DJ
    Cell Death Dis; 2016 May; 7(5):e2238. PubMed ID: 27228353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
    Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
    Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia
    Wang J; Zhou H
    Acta Pharm Sin B; 2020 Oct; 10(10):1866-1879. PubMed ID: 33163341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials.
    Wang J; Toan S; Zhou H
    Pharmacol Res; 2020 Jun; 156():104771. PubMed ID: 32234339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remifentanil Induces Cardio Protection Against Ischemia/Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress Through the Maintenance of Zinc Homeostasis.
    Sheng M; Zhang G; Wang J; Yang Q; Zhao H; Cheng X; Xu Z
    Anesth Analg; 2018 Jul; 127(1):267-276. PubMed ID: 29771714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury.
    Maneechote C; Palee S; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2017 Nov; 21(11):2643-2653. PubMed ID: 28941171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted mitochondrial drugs for treatment of myocardial ischaemia-reperfusion injury.
    Peng JF; Salami OM; Lei C; Ni D; Habimana O; Yi GH
    J Drug Target; 2022 Sep; 30(8):833-844. PubMed ID: 35652502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective.
    Zhou M; Yu Y; Luo X; Wang J; Lan X; Liu P; Feng Y; Jian W
    Cardiology; 2021; 146(6):781-792. PubMed ID: 34547747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCU Up-regulation contributes to myocardial ischemia-reperfusion Injury through calpain/OPA-1-mediated mitochondrial fusion/mitophagy Inhibition.
    Guan L; Che Z; Meng X; Yu Y; Li M; Yu Z; Shi H; Yang D; Yu M
    J Cell Mol Med; 2019 Nov; 23(11):7830-7843. PubMed ID: 31502361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.
    Lejay A; Fang F; John R; Van JA; Barr M; Thaveau F; Chakfe N; Geny B; Scholey JW
    J Mol Cell Cardiol; 2016 Feb; 91():11-22. PubMed ID: 26718721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria and Pharmacologic Cardiac Conditioning-At the Heart of Ischemic Injury.
    Lotz C; Herrmann J; Notz Q; Meybohm P; Kehl F
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33810024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of metabolism by mitochondrial enzyme acetylation in cardiac ischemia-reperfusion injury.
    Herr DJ; Singh T; Dhammu T; Menick DR
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165728. PubMed ID: 32068115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grpel2 alleviates myocardial ischemia/reperfusion injury by inhibiting MCU-mediated mitochondrial calcium overload.
    Yang R; Zhang X; Xing P; Zhang S; Zhang F; Wang J; Yu J; Zhu X; Chang P
    Biochem Biophys Res Commun; 2022 Jun; 609():169-175. PubMed ID: 35447394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.
    Paradies G; Paradies V; Ruggiero FM; Petrosillo G
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1341-H1352. PubMed ID: 30095969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.